No PMI PMI Unadjusted HR (95% CI) p value 1 Adjusted HR(95% CI) p value Total population (n¼927) n¼809 n¼118 Cardiac death 35 (4.3) 5 (4.2) 1.02 (0.40-2.61) 0.96 0.57 (0.20-1.62) 0.29 All-cause death 76 (9.4) 14 (11.9) 1.30 (0.73-2.29) 0.37 0.95 (0.52-1.73) 0.86 Spontaneous MI 3 (0.4) 3 (2.5) 7.14 (1.44-35.38) 0.02 4.76 (0.95-23.97) 0.06 Cardiac death or MI 35 (4.3) 7 (5.9) 1.45 (0.64-3.27) 0.37 0.90 (0.37-2.15) 0.81 CVA 40 (4.9) 6 (5.1) 1.08 (0.46-2.54) 0.87 0.63 (0.25-1.60) 0.33 Repeat revascularization 69 (8.5) 7 (5.9) 0.73 (0.33-1.58) 0.42 0.62 (0.27-1.44) 0.26 MACCE 158 (19.5) 26 (22.0) 1.19 (0.78-1.80) 0.42 0.97 (0.63-1.49) 0.88 Data are presented as n (%). CI ¼ confidence interval; CVA ¼ cerebrovascular accident; HR ¼ hazard ratio; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; MACCE ¼ major adverse cardiac and cerebrovascular event; PMI ¼ periprocedural MI 1 Adjusted covariates include LVEF (%), bridge collaterals, and multivessel disease.
RESULTS Four studies comprising two randomized control trials (SYNTAX and PRECOMBAT) and two observational studies (Maincompare and CREDO-Kyoto), with a total of 3372 patients were included. 1248 patients (37%) had complex coronary artery disease (SS>33). Over a mean follow up of 4.9 years, no significant difference in all-cause mortality was observed between PCI and CABG irrespective of SYNTAX score strata (Figure 1) . Similar findings were observed for cardiovascular mortality (SS 32 RR 0.85; 95% 0.41-1.77; I2 66% for PCI vs. CABG; SS >33 RR 1.25; 95% CI 0.92-1.69; I2 29% for PCI vs. CABG).
CONCLUSIONS Patients with LM disease appear to have similar risks of mortality after PCI with DES or CABG regardless of coronary artery disease burden or complexity during long term follow up. , acute thrombosis or embolism(6, 1.5%), perforation or dissection (4, 1.0%), retroperitoneal hematoma(3, 0.7%) and acute side branch closure(2, 0.5%); The third was the comorbidity factors (29, 7.2%), including septic shock(11, 2.7%), cerebral infarction(10, 2.5%), pulmonary embolism(5,1.2%) and multiple organ failure(3, 0.7%); The last was medicine factors (14, 3.5%), including intracranial hemorrhage(8, 2.0%), massive gastrointestinal hemorrhage(5, 1.2%) and anaphylactic shock (1, 0.2%). 47.3% (190) of the dead cases had some sort of medical defects, including indication (4, 1.0%), rescue measures (60, 14.9%), strategy selection(107, 26.6%) or procedure issue (19, 4.7%). There is no significant difference of the mortality from 2010 to 2013 (2.23%, 2.55%, 1.94% and 2.48% respectively).
CONCLUSIONS Mortality of acute myocardial infarction remains high, which have a variety of causes, by order of disease itself, procedure, comorbidity and medicine factors. The three leading causes of death were cardiogenic shock, mechanical complications and early stent thrombosis. Analysis of death causes may contribute to facilitate 
